Top Headlines

Spain to build its first vaccine plant

The Spanish Ministry of Health is leading a €60m ($84.9m) programme that will build the country’s first vaccine production facility and use Novavax’s recombinant virus-like-particle (VLP) technology.

Dow to shut 3 US ethylene plants

Dow Chemical is closing three US manufacturing plants, including an ethylene production unit in Hahnville, Louisiana in a further bid to expand its specialty chemicals business.

Pharma: people on the move

in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including the new president of Sanofi-Aventis France.

Lantus cancer link research flawed says Sanofi; mulls R&D restructuring

Sanofi-Aventis has moved to defend its long-acting diabetes treatment Lantus (insulin glargine) and says that recent research linking it to the development of cancer is of “poor quality.”

PSI collaborates with Microfluidics

Particle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise.

News in brief

Today's headlines across the Pharmaceutical industry

Medidata inks EDC deal with Roche from Outsourcing-Pharma.com

Medidata has followed up its successful IPO by inking a deal with Roche, which is reported to be pulling out of PhRMA and the ABPI, to provide the Swiss pharma with an enterprise-wide electronic EDC system.

PDS’ new US office has European focus from Outsourcing-Pharma.com

UK contracting group Pharmaceutical Development Services (PDS) has set up an office in North Carolina, US to court North America pharma firms for the European development sector.

Chiltern sets up in Hungary from Outsourcing-Pharma.com

UK group Chiltern International has opened an office in Budapest Hungary, joining the growing number of CRO players to set up in the CEE.

Covance doubles capacity at Madison site from Outsourcing-Pharma.com

Covance has doubled the capacity for large-scale, long-term stability and release programmes at its facility in Madison, Wisconsin, US.

On your radar